4
Changes in Ownership
Neurogene Inc. Filed Acc 0001209191-16-108183
Options or other derivatives
- VP Global Regulatory & Quality acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mitchell David Chilton VP Global Regulatory & Quality | 2016-03-10 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…